No abstract available
Keywords:
Atrial fibrillation; DPP4 inhibitors; GLP1 analogues; Insulin; Metformin; Sulfonylureas.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Atrial Fibrillation / chemically induced*
-
Atrial Fibrillation / diagnosis
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Dipeptidyl-Peptidase IV Inhibitors / adverse effects
-
Female
-
Glucagon-Like Peptide 1 / adverse effects
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Insulin / adverse effects
-
Male
-
Metformin / adverse effects
-
Middle Aged
-
Risk Assessment
-
Sulfonylurea Compounds / adverse effects
Substances
-
Dipeptidyl-Peptidase IV Inhibitors
-
Hypoglycemic Agents
-
Insulin
-
Sulfonylurea Compounds
-
Glucagon-Like Peptide 1
-
Metformin